Angehrn Z[au] - Search Results

Year	Number of Results
2019	2
2020	4
2021	1
2022	2
2023	1
2024	0

1

Health Outcome Prioritization in Alzheimer's Disease: Understanding the Ethical Landscape.

McKeown A, Turner A, Angehrn Z, Gove D, Ly A, Nordon C, Nelson M, Tochel C, Mittelstadt B, Keenan A, Smith M, Singh I. McKeown A, et al. Among authors: angehrn z. J Alzheimers Dis. 2020;77(1):339-353. doi: 10.3233/JAD-191300. J Alzheimers Dis. 2020. PMID: 32716354 Free PMC article. Review.

2

Artificial Intelligence and Machine Learning Applied at the Point of Care.

Angehrn Z, Haldna L, Zandvliet AS, Gil Berglund E, Zeeuw J, Amzal B, Cheung SYA, Polasek TM, Pfister M, Kerbusch T, Heckman NM. Angehrn Z, et al. Front Pharmacol. 2020 Jun 18;11:759. doi: 10.3389/fphar.2020.00759. eCollection 2020. Front Pharmacol. 2020. PMID: 32625083 Free PMC article. Review.

3

Challenges for Optimizing Real-World Evidence in Alzheimer's Disease: The ROADMAP Project.

Gallacher J, de Reydet de Vulpillieres F, Amzal B, Angehrn Z, Bexelius C, Bintener C, Bouvy JC, Campo L, Diaz C, Georges J, Gray A, Hottgenroth A, Jonsson P, Mittelstadt B, Potashman MH, Reed C, Sudlow C, Thompson R, Tockhorn-Heidenreich A, Turner A, van der Lei J, Visser PJ; ROADMAP Consortium. Gallacher J, et al. Among authors: angehrn z. J Alzheimers Dis. 2019;67(2):495-501. doi: 10.3233/JAD-180370. J Alzheimers Dis. 2019. PMID: 30584137 Free PMC article.

4

Prediction of successful labor induction in persons with a low Bishop score using machine learning: Secondary analysis of two randomized controlled trials.

D'Souza R, Doyle O, Miller H, Pillai N, Angehrn Z, Li P, Ispas-Jouron S. D'Souza R, et al. Among authors: angehrn z. Birth. 2023 Mar;50(1):234-243. doi: 10.1111/birt.12691. Epub 2022 Dec 21. Birth. 2023. PMID: 36544398 Clinical Trial.

5

ENTIMOS: A Discrete Event Simulation Model for Maximising Efficiency of Infusion Suites in Centres Treating Multiple Sclerosis Patients.

Lacinova K, Thokala P, Nicholas R, Dobay P, Scalfaro E, Angehrn Z, Brennan R, Boer I, Lines C, Adlard N. Lacinova K, et al. Among authors: angehrn z. Appl Health Econ Health Policy. 2022 Sep;20(5):731-742. doi: 10.1007/s40258-022-00733-0. Epub 2022 May 19. Appl Health Econ Health Policy. 2022. PMID: 35585305 Free PMC article.

6

Ethical and Social Implications of Using Predictive Modeling for Alzheimer's Disease Prevention: A Systematic Literature Review.

Angehrn Z, Sostar J, Nordon C, Turner A, Gove D, Karcher H, Keenan A, Mittelstadt B, de Reydet-de Vulpillieres F. Angehrn Z, et al. J Alzheimers Dis. 2020;76(3):923-940. doi: 10.3233/JAD-191159. J Alzheimers Dis. 2020. PMID: 32597799

7

Secukinumab's effect on structural damage progression in psoriatic arthritis: longitudinal mixture modelling of FUTURE-1 and FUTURE-5.

Luttringer O, Fox T, Pricop L, Gaillez C, Karcher H, Wiecek W, Angehrn Z, Amzal B. Luttringer O, et al. Among authors: angehrn z. Clin Exp Rheumatol. 2021 Sep-Oct;39(5):931-937. doi: 10.55563/clinexprheumatol/ic89a8. Epub 2020 Nov 17. Clin Exp Rheumatol. 2021. PMID: 33253089 Free article.

8

Ethical and social implications of using predictive modeling for Alzheimer's disease prevention: a systematic literature review protocol.

Angehrn Z, Nordon C, Turner A, Gove D, Karcher H, Keenan A, Neumann M, Sostar J, de Reydet de Vulpillieres F. Angehrn Z, et al. BMJ Open. 2019 Mar 3;9(3):e026468. doi: 10.1136/bmjopen-2018-026468. BMJ Open. 2019. PMID: 30833325 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year